TEVA PDUFA decision: a positive outcome, +5.9%

On October 9, 2026, Teva Pharmaceutical Industries Limited reached its PDUFA decision. The result was a positive outcome, and the stock moved +5.9% in the window around the event. It had already run +6.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.